Skip to main content

diaTribe’s Best Articles of 2022

Published: 12/20/22 12:55 pm
By Andrew Briskin

Over the past year, diaTribe has published powerful stories each week to help improve the lives of people with diabetes. From new medications to the latest in diabetes tech, read our 10 most popular articles from 2022. 

10. 10 Tips to Improve Your Time in Range

Time in Range (TIR) is an effective tool to use in your daily diabetes management, but how can you actually spend more of your day in range? Read this article for some helpful tips on how to improve your TIR.

9. New Recommendations on CGM Use Published Worldwide

diaTribe and the Time in Range Coalition, in a global effort to raise the awareness and adoption of Time in Range and the use of continuous glucose monitors (CGM), published an article in a world-renowned medical journal that sets the standards for CGM use in clinical trials.

8. Nerve Damage in Your Hands and Feet From Diabetes

Having diabetes puts you at risk for nerve damage in your extremities – a condition known as peripheral neuropathy. Here are steps you can take to maintain the health of your nervous system, as recommended in the latest ADA Standards of Care.

7. Vertex Releases New Data on Potential Cure for Type 1 Diabetes

For many years, a cure for type 1 diabetes has only been a pipe dream for the millions of people living with type 1 diabetes. New data from Vertex Pharmaceuticals on the first people to receive a revolutionary cell therapy for type 1 suggests a significant step forward towards a cure. 

6. FDA Approves Tzield (Teplizumab) to Delay Type 1 Diabetes

In November, the FDA has approved Provention Bio’s Tzield (teplizumab), a new therapy that could delay the onset of type 1 diabetes by an average of 2 years. Find out about screening and how to know whether treatment with Tzield may be right for you.

5. How to Lower Morning Blood Sugar

Trying to learn how to lower morning blood sugar? Here’s why your glucose levels rise in the morning and a few things you can try to keep them in range.

4. New Law to Cap Insulin at $35

The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for those on Medicare. Find out how the new law could lower your prescription drug costs.

3. Diabetes-Friendly Sushi – Your Ultimate Guide

Sushi is a favorite dish for many, but navigating this carb-heavy food can pose a challenge for those with diabetes. Learn more about the varieties of sushi, nutrition information, and tips for enjoying diabetes-friendly sushi.

2. Dexcom G7 Approved by FDA

The long-awaited FDA clearance of Dexcom G7 is finally here! G7 improves on Dexcom’s current continuous glucose monitoring (CGM) system, the G6, with greater accuracy, smaller size, easier insertion, and more.

1. FDA Approves Mounjaro (Tirzepatide) for Diabetes Treatment

Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been shown to dramatically lower A1C and weight in clinical trials

What do you think?

About the authors

Andrew Briskin joined the diaTribe Foundation in 2021 after graduating from the University of Pennsylvania with a degree in Health and Societies . Briskin is an Editor for diaTribe Learn.... Read the full bio »